Literature DB >> 11282417

Glutamate signalling in non-neuronal tissues.

T M Skerry1, P G Genever.   

Abstract

Since the discovery of its role in the CNS, glutamate, together with its involvement in signalling at synapses, has been the subject of a vast amount of research. More recently, it has become clear that glutamate signalling is also functional in non-neuronal tissues and occurs in sites as diverse as bone, pancreas and skin. These findings raise the possibility that glutamate acts as a more widespread 'cytokine' and is able to influence cellular activity in a range of tissue types. The impact of these discoveries is significant because they offer a rapid way to advance the development of therapeutics. Agents developed for use in neuroscience applications might be beneficial in the modulation of pathology peripherally, impacting on conditions such as osteoporosis, diabetes and wound healing.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11282417     DOI: 10.1016/s0165-6147(00)01642-4

Source DB:  PubMed          Journal:  Trends Pharmacol Sci        ISSN: 0165-6147            Impact factor:   14.819


  87 in total

1.  Glutamate antagonists: deadly liaisons with cancer.

Authors:  E A Cavalheiro; J W Olney
Journal:  Proc Natl Acad Sci U S A       Date:  2001-05-22       Impact factor: 11.205

2.  mGlu Receptors and Cancerous Growth.

Authors:  Jessica Teh; Suzie Chen
Journal:  Wiley Interdiscip Rev Membr Transp Signal       Date:  2011-10-25

Review 3.  Glutamate pharmacology and metabolism in peripheral primary afferents: physiological and pathophysiological mechanisms.

Authors:  Kenneth E Miller; E Matthew Hoffman; Mathura Sutharshan; Ruben Schechter
Journal:  Pharmacol Ther       Date:  2011-01-26       Impact factor: 12.310

Review 4.  Organic anion transport is the primary function of the SLC17/type I phosphate transporter family.

Authors:  Richard J Reimer; Robert H Edwards
Journal:  Pflugers Arch       Date:  2003-06-17       Impact factor: 3.657

Review 5.  Intercellular glutamate signaling in the nervous system and beyond.

Authors:  David E Featherstone
Journal:  ACS Chem Neurosci       Date:  2009-10-09       Impact factor: 4.418

6.  Glutamatergic elements in an excitability and circumnutation mechanism.

Authors:  Maria Stolarz; Elzbieta Król; Halina Dziubinska
Journal:  Plant Signal Behav       Date:  2010-09-01

7.  Association of GRM4 gene polymorphisms with susceptibility and clinicopathological characteristics of osteosarcoma in Guangxi Chinese population.

Authors:  Kun Wang; Jinmin Zhao; Maolin He; Mitra Fowdur; Tenglong Jiang; Shuju Luo
Journal:  Tumour Biol       Date:  2015-08-15

8.  Poly(γ-Glutamic Acid) as an Exogenous Promoter of Chondrogenic Differentiation of Human Mesenchymal Stem/Stromal Cells.

Authors:  Joana C Antunes; Roman Tsaryk; Raquel M Gonçalves; Catarina Leite Pereira; Constantin Landes; Christoph Brochhausen; Shahram Ghanaati; Mário A Barbosa; C James Kirkpatrick
Journal:  Tissue Eng Part A       Date:  2015-04-30       Impact factor: 3.845

9.  A peripheral neuroimmune link: glutamate agonists upregulate NMDA NR1 receptor mRNA and protein, vimentin, TNF-alpha, and RANTES in cultured human synoviocytes.

Authors:  Terry A McNearney; Yinghong Ma; Yueping Chen; Giulio Taglialatela; Huaizhi Yin; Wen-Ru Zhang; Karin N Westlund
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2009-12-09       Impact factor: 3.619

10.  Role of prostanoid production and receptors in the regulation of retinal endogenous amino acid neurotransmitters by 8-isoprostaglandin E2, ex vivo.

Authors:  Min Zhao; Christopher J Destache; Sunny E Ohia; Catherine A Opere
Journal:  Neurochem Res       Date:  2009-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.